6701 - 6725 of 8825 Results
Title
Year
-
RESTRICTEDTitle: Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approachJournal Name: NeuropeptidesPublisher: Elsevier BVVol: 96Issue #:Start Page: 102283End Page: 102283Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.npep.2022.102283Citation Count: 11
-
OPENTitle: Spontaneous changes in brain striatal dopamine synthesis and storage dynamics ex vivo reveal end-product feedback-inhibition of tyrosine hydroxylaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 212Issue #:Start Page: 109058End Page: 109058Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109058Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109058Citation Count: 9
-
OPENTitle: Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse modelJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 218Issue #:Start Page: 109213End Page: 109213Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109213Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109213Citation Count: 11
-
RESTRICTEDTitle: Special Issue on new therapeutic approaches to Parkinson diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 208Issue #:Start Page: 108998End Page: 108998Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.108998Citation Count: 5
-
OPENTitle: Anxiety in Parkinson's disease: A resting-state high density EEG studyJournal Name: Neurophysiologie CliniquePublisher: Elsevier BVVol: 52Issue #: 3Start Page: 202End Page: 211Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neucli.2022.01.001Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S0987705322000016?via%3DihubCitation Count: 20
-
OPENTitle: Biomarkers and non-motor symptoms as a function of motor symptom asymmetry in early Parkinson's diseaseJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 177Issue #:Start Page: 108419End Page: 108419Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108419Best OA location URL: https://doi.org/10.1016/j.neuropsychologia.2022.108419Citation Count: 20
-
RESTRICTEDTitle: Preserved motor memory in Parkinson's diseaseJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 167Issue #:Start Page: 108161End Page: 108161Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108161Citation Count: 15
-
RESTRICTEDTitle: Co-registration of Imaging Modalities (MRI, CT and PET) to Perform Frameless Stereotaxic Robotic Injections in the Common MarmosetJournal Name: NeurosciencePublisher: Elsevier BVVol: 480Issue #:Start Page: 143End Page: 154Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.11.009Citation Count: 12
-
RESTRICTEDTitle: Functional Interaction Between α-Synuclein and Nurr1 in Dopaminergic NeuronsJournal Name: NeurosciencePublisher: Elsevier BVVol: 506Issue #:Start Page: 114End Page: 126Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2022.10.011Citation Count: 2
-
OPENTitle: How should we be using biomarkers in trials of disease modification in Parkinson’s disease?Journal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 12Start Page: 4845End Page: 4869Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awad265Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad265/51034903/awad265.pdfCitation Count: 43
- Stability Changes in Fall-Prone Individuals With Parkinson Disease Following Reactive Step Training2023RESTRICTEDTitle: Stability Changes in Fall-Prone Individuals With Parkinson Disease Following Reactive Step TrainingJournal Name: Journal of Neurologic Physical TherapyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 48Issue #: 1Start Page: 46End Page: 53Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/npt.0000000000000442Citation Count: 15
-
OPENTitle: Functional alterations in resting‐state networks for Theory of Mind in Parkinson's diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 59Issue #: 6Start Page: 1213End Page: 1226Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ejn.16145Best OA location URL: https://doi.org/10.1111/ejn.16145Citation Count: 3
-
OPENTitle: Genomics transformer for diagnosing Parkinson's diseaseJournal Name: 2022 IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI)Publisher: IEEEVol:Issue #:Start Page: 01End Page: 04Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/bhi56158.2022.9926815Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9942707Citation Count: 11
-
RESTRICTEDTitle: Shifting the trajectory of therapeutic development for neurological and psychiatric disordersJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 15Issue #: 720Start Page: eadg4775End Page: eadg4775Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.adg4775Citation Count: 10
-
OPENTitle: Saturation mutagenesis of α-synuclein reveals monomer fold that modulates aggregationJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 43Start Page: eadh3457End Page: eadh3457Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adh3457Best OA location URL: https://doi.org/10.1126/sciadv.adh3457Citation Count: 16
-
OPENTitle: PFTK1 kinase regulates axogenesis during development via RhoA activationJournal Name: BMC BiologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page: 240End Page: 240Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12915-023-01732-wBest OA location URL: https://bmcbiol.biomedcentral.com/counter/pdf/10.1186/s12915-023-01732-wCitation Count: 2
-
OPENTitle: Regulation of expression quantitative trait loci by SVA retrotransposons within the major histocompatibility complexJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol:Issue #:Start Page: 2304End Page: 2318Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/15353702231209411Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10903234/pdf/10.1177_15353702231209411.pdfCitation Count: 10
-
OPENTitle: Longitudinal dysregulation of long non-coding RNAs in Parkinson’s diseaseJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 248Issue #: 20Start Page: 1780End Page: 1784Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/15353702231198078Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10792423/pdf/10.1177_15353702231198078.pdfCitation Count: 2
-
OPENTitle: Evaluating the ability of a predictive vision-based machine learning model to measure changes in gait in response to medication and DBS within individuals with Parkinson’s diseaseJournal Name: BioMedical Engineering OnLinePublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page: 120End Page: 120Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12938-023-01175-yBest OA location URL: https://biomedical-engineering-online.biomedcentral.com/counter/pdf/10.1186/s12938-023-01175-yCitation Count: 11
-
RESTRICTEDTitle: PPMI 2.O New Science/New Cohorts - Transforming PPMI (2490)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.2490Citation Count: 7
-
RESTRICTEDTitle: Carepartner Communication on Parkinson Disease Psychosis (4116)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4116Citation Count: 0
-
RESTRICTEDTitle: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418Citation Count: 1
-
RESTRICTEDTitle: Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 18_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.98.18_supplement.1529Citation Count: 4
-
RESTRICTEDTitle: Incidence of Parkinson Disease in North America (P1-1.Virtual)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 18_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.98.18_supplement.2665Citation Count: 3
-
RESTRICTEDTitle: Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4402Citation Count: 0